Urinary cytokine levels in apparently healthy cats and cats with chronic kidney disease

Journal of Feline Medicine and Surgery

Volumn 15, Issue 2, 2013, Pages 99-104

  Habenicht, Lauren M ^a   Webb, Tracy L ^a   Clauss, Laurie A ^b   Dow, Steven W ^a   Quimby, Jessica M ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b CatTails Feline Health Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; CHRONIC KIDNEY FAILURE; FEMALE; GENE EXPRESSION REGULATION; MALE; METABOLISM; PHYSIOLOGY; URINE;

ANIMALS; CAT DISEASES; CATS; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; MALE; RENAL INSUFFICIENCY, CHRONIC;

EID: 84873855176     PISSN: 1098612X     EISSN: 15322750     Source Type: Journal    
DOI: 10.1177/1098612X12461007     Document Type: Article

References (27)

1. Lulich JP,O'Brien TD,Osborne CA,Polzin DJ.Feline renal failure:questions, answers, questions.Compend Contin Educ Vet. 1992;14:127-152.
2. Boyd LM,Langston C,Thompson K, et al.Survival in cats with naturally occurring chronic kidney disease (2000-2002).J Vet Intern Med. 2008;22:1111-1117.
3. Lawler DF,Evans RH,Chase K, et al.The aging feline kidney: a model mortality antagonist?.J Feline Med Surg. 2006;8:363-371.
4. DiBartola SP,Rutgers HC,Zack PM,Tarr MJ.Clinicopathologic findings associated with chronic renal disease in cats: 74 cases (1973-1984).J Am Vet Med Assoc. 1987;190:1196-1202.
5. Nangaku M,Fujita T.Activation of the renin-angiotensin system and chronic hypoxia of the kidney.Hypertens Res. 2008;31:175-184.
6. Harris RC,Neilson EG.Toward a unified theory of renal progression.Annu Rev Med. 2006;57:365-380.
7. Siragy HM,Carey RM.Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease.Am J Nephrol. 2010;31:541-550.
8. Elliott J,Watson ADJBonagura JDTwedt DC, ed. St Louis, MO: Saunders Elsevier; 883-892.
9. Plotnick A.Feline chronic renal failure: long-term medical management.Compend Contin Educ Vet. 2007;29:342-344.
10. Bethesda, MD: National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases; 2010:.
11. Vaden SL,Levine JF,Lees GE, et al.Renal biopsy: a retrospective study of methods and complications in 283 dogs and 65 cats.J Vet Intern Med. 2005;19:794-801.
12. Honkanen EO,Teppo AM,Gronhagen-Riska C.Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis.Kidney Int. 2000;57:2343-2349.
13. Scaglione R,Argano C,Corrao S, et al.Transforming growth factor beta1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: a 24-week randomized controlled trial.J Hypertens. 2005;23:657-664.
14. Tam FW,Sanders JS,George A, et al.Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis.Nephrol Dial Transplant. 2004;19:2761-2768.
15. Sheu JN,Chen SM,Meng MH,Lue KH.The role of serum and urine interleukin-8 on acute pyelonephritis and subsequent renal scarring in children.Pediatr Infect Dis J. 2009;28:885-890.
16. Branton MH,Kopp JB.TGF-beta and fibrosis.Microbes Infect. 1999;1:1349-1365.
17. Murakami K,Takemura T,Hino S,Yoshioka K.Urinary transforming growth factor-beta in patients with glomerular diseases.Pediatr Nephrol. 1997;11:334-336.
18. Bobkova IN,Chebotareva NV,Kozlovskaia LV, et al.Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta 1 as an indicator of chronic glomerulonephritis progression.Ter Arkh. 2006;78:9-14.
19. Arata S,Ohmi A,Mizukoshi F, et al.Urinary transforming growth factor beta 1 in feline chronic renal failure.J Vet Med Sci. 2005;67:1253-1255.
20. Eardley KS,Zehnder D,Quinkler M, et al.The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease.Kidney Int. 2006;69:1189-1197.
21. Bobkova IN,Kozlovskaia LV,Rameeva AS, et al.Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis.Ter Arkh. 2007;79:10-15.
22. Mayer G.Capillary rarefaction, hypoxia, VEGF and angiogenesis in chronic renal disease.Nephrol Dial Transplant. 2011;26:1132-1137.
23. Chakrabarti S,Syme HM,Elliott J.Urinary vascular endothelial growth factor as a marker of renal hypoxia in cats.J Vet Int Med. 2011;25:720.
24. Kerl ME,Cook CR.Glomerular filtration rate and renal scintigraphy.Clin Tech Small Anim Pract. 2005;20:31-38.
25. Torabinejad S,Mardani R,Habibagahi J, et al.Urinary monocyte chemotactic protein-1 and transforming growth factor-β in systemic lupus erythematosus.Indian J Nephrol. 2012;22:5-12.
26. Taha AS,Grant V,Kelly RW.Urinalysis for interleukin-8 in the non-invasive diagnosis of acute and chronic inflammatory diseases.Postgrad Med J. 2003;79:159-163.
27. Wood M,Breitschwerdt E,Vaden SL,Nordone S.Immunologic testing of dog urine requires neutralization of matrix effects to allow for accurate measurement of IL-6 concentrations.J Vet Int Med. 2010;24:770.